← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Molecular Design International, Inc.
Memphis, TN
$2,720,649
Total funding
7
Grants
Funding over time
peak $869.4K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,720,649 · 7
By mechanism
R44$2,213,249 · 2
R43$299,001 · 3
R41$208,399 · 2
Investigators at Molecular Design International, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
NON-IRRITATING RETINOIDS FOR THE TREATMENT OF AGING$869,375
R44 · FY2005 · AR
Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative$599,008
R44 · FY2008 · GM
Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative$597,741
R44 · FY2009 · GM
NON-IRRITATING RETINOIDS FOR THE TREATMENT OF AGING$147,125
R44 · FY2006 · AR
Novel Topical Therapy for Diabetic Retinopathy using Beta-Adrenergic Receptor Ago$108,399
R41 · FY2011 · EY
Topical Skin Treatment to Facilitate Wound Healing in the Aged Population$100,001
R43 · FY2008 · GM
Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative$100,000
R43 · FY2006 · GM
DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES$100,000
R41 · FY2001 · GM
NON-IRRITATING RETINOIDS FOR THE TREATMENT OF AGING$99,000
R43 · FY2003 · AR